Alnylam Pharmaceuticals
ALNY
#443
Rank
ยฃ39.51 B
Marketcap
ยฃ299.14
Share price
1.06%
Change (1 day)
53.20%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company